{"id":"W2950542774","doi":"10.1097/01.hs9.0000559388.41193.da","title":"PF294 IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"","keywords":"Medicine; International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; CHOP; Rituximab; Oncology; Lymphoma; Regimen; Gastroenterology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690703,0.0003070283,0.0006802881,0.0001239029,0.0001416267,0.0004561724,0.0001982963,0.0003495717,0.001371667],"category_scores_gemma":[0.0006641785,0.0001257354,0.0004597763,0.0002144239,0.0001727866,0.0002748737,0.0001815955,0.0007031213,0.0001963556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003230744,"about_ca_system_score_gemma":0.0003282855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005663151,"about_ca_topic_score_gemma":0.001227237,"domain_scores_codex":[0.9998507,0.00006995549,0.000007974967,0.0000305172,0.00001649246,0.00002434459],"domain_scores_gemma":[0.9997473,0.00005850027,0.00008174248,0.00001738777,0.00001670216,0.0000783594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5193148,0.01065868,0.2155825,0.0006899952,0.002458662,0.0004670611,0.000227902,0.003041842,0.02876607,0.000152125,0.006472339,0.2121679],"study_design_scores_gemma":[0.07960902,0.2655434,0.6365509,0.00008721602,0.002236672,0.001187094,0.0001531623,0.003488876,0.004243901,0.0002970643,0.006561499,0.00004114249],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975076,0.00140645,0.00005868877,0.0001045683,0.00002437648,0.00005319643,0.0003040147,0.00002384041,0.0005172376],"genre_scores_gemma":[0.998311,0.0004258209,0.000121617,0.0001264286,0.00003038318,0.00003608005,0.0005835484,0.000003894027,0.0003613359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001371667,"threshold_uncertainty_score":0.004588723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01167698582169717,"score_gpt":0.2738387238202887,"score_spread":0.2621617379985915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}